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Abstract
Background: The aim of this study was to investigate the beliefs and attitudes of trainee surgeons regarding
placebo interventions, in surgical practice and in research, and to compare them to those of senior orthopaedic
surgeons.
Methods: An invitation to participate in an online survey was sent to all the email addresses in the members’
database of the British Orthopaedic Trainees Association (BOTA).
Results: All 987 members of BOTA were invited to participate in the survey and 189 responded (19 %). The majority of
trainees think that the placebo effect is real (88 %), has therapeutic benefits (88 %) and that placebo manipulations are
permissible (98 %). Sixty per cent of respondents agree that placebo can be used outside of research, most commonly,
to distinguish between organic and non-organic symptoms (36 %). Trainees are more likely than senior surgeons to
use placebo for pain management (34 % vs. 12 %). They are mainly concerned about the risk of side effects associated
with the use of placebo (80 %) and prefer placebo interventions with minimal invasiveness. Seventy-three per cent
respondents would recruit patients into the proposed randomised controlled surgical trial.
Conclusions: The views regarding efficacy, permissibility and indications for placebo among trainees are similar to
those of orthopaedic consultants. Orthopaedic trainees regard placebo as permissible and show willingness to recruit
into placebo-controlled trials. However, they seem to have limited understanding of mechanisms of placebo effect and
underestimate its ubiquity.
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Background
Surgical interventions are being increasingly used and the
number of surgical procedures performed rises each year
[1, 2]. Technological advances have created new possibil-
ities for surgical intervention. Yet, unlike drug products,
verifying the efficacy of new procedures is not currently
mandatory [3]. The issue of true efficacy is particularly im-
portant in case of surgical interventions aimed primarily
at improving “soft” outcome measures, such as quality of
life, pain or function, as these subjective measures are
prone to bias from the placebo effect; unlike “hard” out-
comes, such as mortality or laboratory measures [4].
The placebo effect refers to an improvement in clinical
symptoms or patients’ well-being in response to placebo
manipulations such as an inactive substance or a proced-
ure that simulates an active therapy, but itself has no
specific effects [5]. The placebo effect is a consequence
of patients’ expectations, verbal and non-verbal sugges-
tions by the treating health professional as well as clas-
sical conditioning [5, 6]. An actual placebo pill or
procedure is not necessary and even a positive consult-
ation or a definitive diagnosis may have a placebo effect,
with more invasive treatments potentially exerting a lar-
ger effect [7–9].
The role of placebo and placebo interventions in rou-
tine clinical practice remains controversial [10–12]. The
majority of physicians admit that they have used placebo
or non-specific treatments [13], but there is little known
about the attitudes of surgeons towards placebo use in
their speciality. Earlier studies suggested that surgeons
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have more defensive attitude than other specialties when
it comes to including their procedures into a definition
of placebo [14]. A recent survey [15] demonstrated that
consultant British orthopaedic surgeons generally agree
with the provided definition of placebo and believe that
placebo in surgery is permissible (96 %), especially in the
context of research. They believe that the placebo effect
is real (92 %) and it has therapeutic effects (77 %). Im-
portantly, over half (58 %) recognise that surgical inter-
ventions may contain a significant placebo component.
However, 42 % responded that they have never per-
formed a procedure that could have a significant elem-
ent of placebo. The survey also demonstrated that
surgeons have limited understanding of the mecha-
nisms underlying the placebo effect and underestimate
its ubiquity. It is important to note that this survey was
conducted among surgeons who were aware of a
placebo-controlled trial being currently undertaken in
the UK, which could have affected their responses. Add-
itionally, it is not known whether these attitudes represent
the beliefs of the whole orthopaedic community or are a
generational phenomenon. Understanding the attitudes of
surgeons towards placebo may help to answer the ques-
tion why there have been so few placebo-controlled trials
of interventional procedures [15].
The aim of this study was to investigate the attitudes
and beliefs of British orthopaedic trainee surgeons to-




Surgical members of the British Orthopaedic Trainees As-
sociation (BOTA) were invited via email to participate in
an online survey. Although not all of the 1,111 nationally
registered UK orthopaedic trainees will be BOTA mem-
bers, this email database was identified as the most
complete contact list available to the authors. The data
collection was open between 28th July and 28th August
2014. A reminder was sent via email at the midpoint of
collection. Permission for use of the email database was
granted by the BOTA. This study was reviewed by the
National Institute for Health Oxford Musculoskeletal Bio-
medical Research Unit Board at the Nuffield Department
of Orthopaedics, Rheumatology and Musculoskeletal Sci-
ences, which decided it did not require a review by an ex-
ternal ethics committee as it was a survey of healthcare
professionals and the participation as well as the answers
were fully anonymous and voluntary.
Survey instrument
A questionnaire used in this study was derived from
previously published surveys to make the results com-
parable with earlier studies [15–18]. Participants were
asked about their age, gender, number of years since
graduation, stage of their training as well as the number
of patients they treat weekly. To assess the degree of
exposure to research ethics and methodology we asked
about their attainments of higher degrees, Good Clin-
ical Practice (GCP) accreditation, proportion of time
spent in research and the number of patients they re-
cruited into a randomised controlled trial (RCT) within
the last 12 months.
To address the controversies surrounding definitions
of placebo, the survey started with three separate defini-
tions and closed questions on whether the participants
agreed with each of them. Two further closed questions
asked whether the respondents believed that the placebo
effect is real, i.e., has a scientific basis, and whether it
has a therapeutic effect. The next three questions were re-
lated to clinical situations, in which the trainees would
consider a placebo, the concerns related to placebo use as
well as understanding of mechanisms underlying the pla-
cebo effect. Participants were also asked how often they
performed or observed operations that they believed to
have a significant placebo component. The section ended
with a direct question on the participants’ overall position
concerning the use of placebo in clinical practice.
The next section sought to investigate attitudes toward
placebo in clinical research; a number of statements were
posed and each response was rated on a 5-point Likert
scale ranging from “strongly disagree” to “strongly agree”.
Finally, respondents were asked to consider a scenario in
which an old and new procedure co-existed, with dis-
agreement over their efficacy and superiority. The respon-
dents were asked to choose the design that they believed
is superior from the scientific perspective. The next ques-
tion asked whether they would personally recruit into a
surgical trial with a placebo arm. Finally, we assessed
whether acceptability is affected by the degree of invasive-
ness of the placebo. Several study designs, with varying
physical invasiveness, were described and participants
were asked to choose the studies they would personally re-
cruit into.
The survey document is in Additional file 1. The sur-
vey was piloted on 11 orthopaedic trainees within
NDORMS to ensure face validity.
Data analysis
Participants entered their responses directly into an on-
line survey (http://www.surveymonkey.net)
The data were summarised using percentages to de-
scribe the responses to each question. A multivariate lo-
gistic regression was used to explore the relationship
between willingness to recruit into a placebo-controlled
surgical trial and respondents’ characteristics. For the
purposes of analysis, this outcome was reduced to a bin-
ary outcome: “would recruit” or “would not recruit”.
Baldwin et al. BMC Surgery  (2016) 16:27 Page 2 of 8
Characteristics tested included; age, gender, training
grade, time since graduation, work load, hospital type,
research experience, higher degrees achieved, number of
patients recruited into an RCT, GCP accreditation, belief
in placebo effect, belief in therapeutic benefit of placebo,
frequency of placebo use, and belief in scientific import-
ance of placebo controls. Questions that overlapped with
a previous survey of Orthopaedic consultants [15] (atti-
tudes on placebo permissibility, indications for utilising
placebo, placebo mechanisms, frequency of placebo use,
belief in the placebo effect and belief in the therapeutic
benefit of placebo) were compared using a χ2 analysis.
All analysis was conducted with SPSS (Version 21).
Results
Respondent characteristics
There were 987 email addresses in the BOTA database
but only 189 members participated in the survey and
152 of them completed the whole questionnaire, a re-
sponse rate of 19 %. The respondents were most male
(83 %), aged between 30 and 39 (77 %), and between 3rd
and 5th year of speciality training (46 %). The majority
worked in a district general hospital (51 %), and treated
31 to 50 patients per week (48 %) (Table 1). Most
participants had another higher degree, in addition to
their primary medical degree (79 %), but only 31 % were
involved in research on a weekly basis. Most (75 %) had
not recruited a patient into a RCT within the last
12 months (Table 2).
Definitions of placebo
The majority of participants (88 %) agreed with the def-
inition of placebo as “any intervention or treatment, that
objectively is known to have no specific effect, but for
which a beneficial outcome occurs as a result of the pa-
tient’s belief in its efficacy” [Definition 1] (Fig. 1). Ten
respondents provided additional comments: nine felt the
definition described placebo effect and not placebo,
since the later could also be harmful and one respondent
disagreed with describing a placebo as a “treatment”.
Slightly fewer participants (81 %) agreed with the def-
inition of placebo for surgical practice, i.e., “an interven-
tion where patients undergo a surgical procedure that
has the appearance of a therapeutic intervention, but
during which the essential therapeutic manoeuvre is
omitted” [Definition 2]. Of the 35 respondents who dis-
agreed nine provided comments, including four who felt
it should be called a “sham surgery” and not a “placebo”,
two participants commented that the definition was too
narrow, i.e., surgical practice was not synonymous with
surgical intervention, two who disagreed purely on eth-
ical grounds, and one respondent commented on the
Table 1 Sample characteristics



















Locum Appointed for Training 15 (8)
Speciality Registrar (ST 3–5) 86 (46)
Speciality Registrar (ST 6–8) 67 (35)
Fellow 13 (7)
Non-training grade Registrar 8 (4)
Table 2 Research experience
Category N Count (%)
Research Involvement 189
2–5 days/week 14 (7)
1 day/week 46 (24)
1–3 days/month 70 (37)
<1 day/month 59 (31)
Additional Higher Degrees 189
BSc or BA 58 (31)
MSc, MA, MPhil or MS 60 (32)










aGood Clinical Practice (GCP)
b Randomised Controlled Trial (RCT) within last 12 months
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fact that the “essential manoeuvre” is often difficult to
determine.
Our final definition explored whether respondents felt a
definition of placebo “should include therapies which are
given by a surgeon in the belief that they are effective and
specific even though, and unknown to the surgeon, they
are in fact non-specific” [Definition 3]. This option was
the most controversial and 59 % of respondents disagreed
with the given definition. Six participants expanded on
their reasons for disagreement: three expressed a funda-
mental objection, stating that if a surgeon believes in the
efficacy, it cannot be classified as placebo, and further
three respondents noted that disagreement over the effi-
cacy of many procedures exists rendering the definition
too broad i.e., too many therapies could be classified as
placebo.
Beliefs about placebo and indications for its use
Most of the respondents believed that the placebo effect
was real and had a scientific basis (88 %), with a similar
proportion believing placebo could provide therapeutic
benefit to patients (88 %); these two factors were associ-
ated (χ2 = 7.66, df = 1, p = 0.006) and were not signifi-
cantly different from the views of consultants.
When asked about the circumstances, in which they
would consider using a placebo procedure, 40 % of
trainees answered that they would not use placebo out-
side of research. The most common scenario, in which
respondents would consider using placebo, was as a
diagnostic tool to distinguish between organic and non-
organic symptoms (36 %) as well as to control pain
(34 %). Fourteen per cent would consider using placebo
to mollify a complaining patient and 7 % would use it to
maintain a good doctor-patient relationship (Table 3).
There was a trend toward a greater use of placebo to
control pain among trainees (34 % vs. 12 %, χ2 = 14.8,
df = 1, p < 0.001), with no difference between trainees
and senior surgeons for all other scenarios.
Concerns over placebo use
The main concerns expressed by trainee surgeons were
similar to those of senior surgeons: the main two issues
were that placebo involved deceiving the patient (59 %)
and risked damaging patient-surgeon trust (55 %). Reser-
vations over legal implications (39 %) and potential side-
effects (30 %) were also commonly expressed. Only 13 %
of trainees would not use placebo because they felt it
was ineffective (Table 3).
Mechanism of the placebo effect
Most participants (92 %) answered that the placebo ef-
fect is a result of psychological mechanisms but only
22 % recognised the role of conditioning and only 20 %
responded there is a physiological basis for the placebo
effect (Table 3). Forty per cent responded that the
Fig. 1 Definitions of placebo. Respondents were asked about their
position: “Agree” or “Disagree” regarding three different definitions
of placebo. The definitions are listed on the y-axis and the cumulative
@percentage of respondents are listed on the x-axis. See body of
manuscripts for wording of each definition




In which on the following situations have you
considered placebo? (more than one option allowed)
180
As a diagnostic tool 64 (36)
When all other therapies have been exhausted 50 (28)
As a treatment for a non-specific symptoms 44 (24)
Instead of surgery, when using surgery was not
justified
39 (22)
As a supplement to surgery 34 (19)
To calm a patient or mollify a complaining patient 25 (14)
To control pain 61 (34)
To maintain a good relationship with a patient 12 (7)
Never as a formal treatment option outside of
research
71 (40)
What are your concerns regarding the use of placebo
in surgery? (more than one option allowed)
176
It involves deception 104 (59)
It endangers patient-surgeon trust 96 (55)
Because of legal problems 68 (39)
Because of possible side effects 52 (30)
It is ineffective 23 (13)
None of the above 22 (13)
In your opinion what is the mechanism behind the
placebo effect? (more than one option allowed)
180
Psychological 166 (92)
Unexplained Factors 68 (38)
The natural course of a disease 72 (40)
Conditioning 40 (22)
Physiological 36 (20)
Positive Energies 5 (3)
Other 6 (3)
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placebo effect was a consequence of the natural history
of a disease and 38 % believed that the placebo effect is
the consequence of as yet unexplained factors. These be-
liefs were not significantly different from those expressed
by senior surgeons.
Frequency of the placebo effect in surgery
Only twenty-one per cent of participants reported that
they had never observed an operation that they believed
to have a significant placebo component. In comparison,
42 % of senior surgeons answered that they had never
performed a procedure that they believed had a signifi-
cant placebo component (21 % vs. 42 %, χ2 = 11.9, df = 1,
p < 0.001). Other trainees reported observing such proce-
dures infrequently: about once a year (36 %) or less than
one case per year 24 %. Only 1.8 % felt they observed op-
erations with placebo components on a weekly basis.
Attitudes toward permissibility of placebo
Attitudes towards permissibility of placebo, in general,
among the trainees were not significantly different from
the previously reported opinions of orthopaedic consul-
tants. When asked whether the use of placebo is permit-
ted if patients gave informed consent, only 2.2 % of
trainees felt that placebo should always be prohibited.
Over a third believed that placebo should only be used
in clinical research trials (36 %), whereas 22 % responded
that placebo could be used in both clinical practice and
clinical research trials. Twenty- nine per cent responded
that placebo could be used in clinical practice if research
supported its evidence. However, fewer (11 %) were
comfortable with the use of placebo in clinical practice if
the supporting evidence was only based on prior experi-
ence, within the department or personal.
Placebo in clinical research
Participants were asked about their opinion regarding
commonly expressed issues on the use of placebo in
clinical research (Fig. 2). The most unanimous view-
point, with over 80 % agreement, was that placebo can
only be used if informed consent is sought, and if pa-
tients in the placebo group are not at risk of serious
harm. Respondents’ views other topics were split, for ex-
ample, 40 % disagreed and 41 % had a neutral stance on
whether using a placebo arm prioritises the interests of
society over those of an individual.
Acceptability of placebo
Out of 152 trainees who answered this question, 47 % pre-
ferred a design comparing new technique with old and
40 % favoured a placebo-controlled study. The remaining
13 % would rather use an alternative design; most often a
trial including all three procedures; although one
respondent suggested two separate trials comparing each
technique, old and new one, to placebo.
At the practical level, 73 % of trainees responded that
they would recruit patients into a proposed trial. The
trainees who preferred the design comparing new treat-
ment with a placebo would “definitely” (30 %) or “prob-
ably” (56 %) recruit patients into such a trial (Fig. 3). Out
of respondents who chose the old versus the new design,
only 11 % would definitely recruit, and 51 % would prob-
ably recruit into it, whereas 13 % would not recruit into
such a trial. Interestingly, four of respondents who sug-
gested an alternative design, with both interventions and
placebo, would not recruit into it.
Placebo invasiveness
We also investigated whether acceptance of placebo sur-
gery depends on the invasiveness of the placebo proced-
ure. Responses were split along the line of whether the
procedure should be arthroscopic or involve open surgery
(Table 4). Several participants (11 %) answered that they
would not recruit and expressed strong ethical objections
against recruiting into any form placebo-controlled surgi-
cal trial.
Willingness to recruit
Willingness to recruit into a placebo-controlled surgical
trial was associated with a belief in the therapeutic effect
of placebos (Odds Ratio [OR] 4.85, 95 % Confidence
Interval [CI] 1.36–17.2), frequent observation of opera-
tions with a placebo component (OR 10.3, 95 % CI
1.97–53.5) and a belief in the scientific importance of
placebo controls (OR 5.17, 95 % CI 1.74–15.3).
Discussion
Summary of main findings
The majority of orthopaedic trainees recognise that sur-
gical procedures can be classified as a placebo but fewer
realise that the placebo effect can be created uninten-
tionally. Most find the use of placebo in clinical practice
ethically acceptable. Deception and the associated dam-
age to trust are the main concerns over the use of pla-
cebo. Most trainees believe the placebo effect has real
and therapeutic effects, explained largely through psy-
chological mechanisms. Considerably fewer would trans-
late their beliefs into clinical practice. The main reason
why trainees would consider using placebo would be to
distinguish organic from non-organic symptoms or to
manage pain.
In the context of research, the importance of protect-
ing an individuals’ right to make informed choices and
the need to minimise risk of harm are the most com-
monly expressed ethical concerns. The scientific validity
of placebo is recognised and this equated with willing-
ness to recruit patients.
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Differences in results in comparison to other surveys
There is no generally accepted definition of placebo
[14, 16]. In our survey most respondents agreed with a
definition of placebo as “beneficial treatment that is
known to have no specific effect” and specifically accepted
that surgical procedures can have a placebo effect. This is
similar to the responses of senior orthopaedic surgeons
[15] but this is in contrast to the earlier study that ob-
served that surgeons did not believe that surgical proce-
dures could be regarded as placebo because they had a
strong therapeutic effect [14].
Physician’s personal expectations [19] as well as posi-
tive consultations and suggestions can generate a pla-
cebo effect [7] and this seems to be appreciated among
physicians [18]. In contrast, fewer orthopaedic trainees
demonstrate understanding of these concepts. Only
41 % would include in a definition of placebo “therapies
believed by the surgeon to be effective and specific even
though, and unknown to the surgeon, they are in fact
non-specific”. While the views of orthopaedic surgeons
toward placebo are not as restrictive as those described
before [14] but it seems that they remain conservative
relative to other specialities.
The respondents would recruit more willingly into stud-
ies with minimally-invasive, arthroscopic, procedures ra-
ther than into open surgery. Indeed, as the invasiveness of
the placebo procedure increases, there is a corresponding
fall in the proportion of trainees willing to recruit patients.
When specifically asked about their concerns about pla-
cebo in research, the most widely held beliefs are that risks
to the participant must be minimised and informed con-
sent granted. The attitudes and concerns of surgeons may
explain, at least to some degree, why the vast majority of
existing placebo-controlled surgical trials investigated
minimally-invasive procedures [20]. It is important to note
that some of the respondents in this survey appreciated
the values of the three-arm design, i.e., of comparing two
surgical procedures head to head as well as to a placebo
intervention; however, they would still not recruit into
such a trial.
Interestingly, in the context of clinical practice, trainees
express a greater level of concern towards patient decep-
tion and subsequent damage to the doctor-patient rela-
tionship rather than potential side effects of placebo use.
Trainees are aware of the need for informed consent and
minimising harm so the obligations placed on them by the
Fig. 3 Scientific acceptability of placebo and willingness to recruit. Please note old versus new therapy comparison refers to an active-control design
Fig. 2 Attitudes toward placebo in clinical research. Respondents were asked to rate their position regarding a number of statements concerning
the use of placebo in clinical research on a 5-point scale with anchors from “Strongly Agree” to “Strongly Disagree”. Statements are listed on the
y-axis and the cumulative percentage of respondents on the x-axis
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Declaration of Helsinki and medical regulatory bodies. Re-
spondents’ opinions on other ethical issues, which are
often a subject of a heated ethical debate, are divided.
The majority of our respondents believe that the pla-
cebo effect is real and that is has therapeutic benefits,
which is similar to our previous survey of orthopaedic
consultants [15] as well as to previous studies which
demonstrated that most doctors believe the placebo ef-
fect is real (68–95 %) and can produce a therapeutic
benefit (68–96 %) [16, 21, 22].
The circumstances in which placebos are used are com-
plex. Among community physicians the most commonly
reported reasons are to treat non-specific symptoms or to
calm a patient [18]. In the hospital settings, it is more
often used to alleviate pain or anxiety [16, 17] and as a
tool to distinguish between organic and non-organic
symptoms. [17, 23] Orthopaedic consultants and trainees
in the UK are most likely to use placebo as a diagnostic
tool, as treatment for non-specific symptoms or when all
the other therapies have been exhausted [15]. The only
significant difference is a greater use of placebo to control
pain among trainees. It is surprising that both groups be-
lieve that only non-organic symptoms may possibly im-
prove after placebo treatment.
Orthopaedic trainees commonly attribute the mechan-
ism of the placebo effect to psychological factors. Our find-
ings are similar to the previously reported beliefs among
orthopaedic consultants as well as physicians [15, 16]. Both
cohorts recognise the role of psychological factors but
underestimate the role of conditioning. However, only one
in five respondents understands the importance of condi-
tioning and the fact that the placebo response involves ac-
tual physiological changes. Confusion also exists over how
the placebo effect differs from the natural history of a dis-
ease [5] and between the true placebo effect, i.e., specific to
the placebo manipulations, and the overall change in the
placebo arm. None of the respondents suggested adding an
observational, non-interventional group, to control for the
natural history of disease. This is concerning as without an
observational group it is not possible to separate a placebo
response into the true placebo effect and non-specific ef-
fects [4]. Furthermore, the absence of a observational arm
results in no baseline from which to evaluate the harms
and benefits of the surgical procedure [20]. However,
placebo-controlled surgical randomised controlled trials
tend not to include an observational group [20]. It is also
concerning that over one third of trainees replied that the
placebo effect is caused by unexplained phenomena.
Most doctors find the use of placebo in clinical prac-
tice acceptable but only a minority have no reservations.
Permissibility depends on the type of placebo and the
circumstances of its use [13]. Evidence supporting pla-
cebo improves acceptability, with clinical research being
a more powerful determinant than personal or depart-
mental experiences alone [15, 16]. Surgeons report using
procedures with a possible placebo element less often
than physicians [13, 15]. This may be related to a more
direct involvement in treatment [24] or it may reflect
the same phenomenon that was reported by Shapiro and
Struening [14], namely, that surgeons acknowledge exist-
ence of placebo effect but are unwilling to admit that
some of the effect of surgical procedure may be associ-
ated with a placebo effect. It is interesting that, com-
pared to senior surgeons, fewer trainees reported that
they have never observed an operation with a placebo
component [15].
Strengths and limitations of this study
The participants were representative of the trainees in the
UK. The responses were generated from all stages of train-
ing and the proportion of males to female (17.5 %) was
also similar to the gender split among current trauma and
orthopaedic registrars [25].
The main limitation of this survey is that the response
rate cannot be accurately calculated as it is not known
how many trainees in the BOTA database actually re-
ceived the invitation to participate. While a low response
rate could be related to the delicate nature of the topic,
the rate was smaller than in the other surveys (46–57 %)
[14, 19, 23] and lower than in the survey of senior ortho-
paedic surgeons (51 %) [14]. It may be that trainees are
less likely to participate in survey research, perhaps
owing to time pressures or survey fatigue. Additionally,
it should be noted that the survey of senior surgeons
[15] was distributed during a research conference, which
might have primed participants to the importance of re-
search and inflated response rates.
Conclusions
There may be an increasing awareness of the frequency
of placebo use amongst junior orthopaedic surgeons.
However, other than a greater belief in the role of
Table 4 Invasiveness of placebo control
Survey Question N Responded
Yes (%)
Would you personally recruit patients into a placebo
controlled trial if the placebo group undergo:
(you may choose more than one answer)
152
Skin incisions only, sufficient to imitate arthroscopic
surgery
89(59)
Skin incisions only, sufficient to imitate open
surgery
37(24)
Incisions sufficient to enable arthroscopic exposure
and inspection of the joint
73(48)
Incisions sufficient to enable open exposure and
inspection of the joint
20(13)
I would not recruit 17(11)
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placebo in pain management, attitudes between trainees
and consultants are highly comparable. Most orthopaedic
trainees believe that the placebo effect is real but its mech-
anisms of actions and its pervasive nature remain under-
appreciated. Without an understanding that the placebo
effect is a component of every medical treatment, the im-
portance of placebo controlled surgical trials cannot be
properly understood. High quality research that changes
practice and improves care can only be successfully under-
taken if there is a general support of the orthopaedic com-
munity. Providing trainees with better training in research
methodology, so that they understand the strengths and
limitations of different trial designs, may facilitate this
process.
Ethics approval and consent to participate
This study was reviewed by the National Institute for
Health Oxford Musculoskeletal Biomedical Research
Unit Board at the Nuffield Department of Orthopaedics,
Rheumatology and Musculoskeletal Sciences, which de-
cided it did not require a review by an external ethics
committee as it was a survey of healthcare professionals
and the participation as well as the answers were fully
anonymous and voluntary.
Availability of supporting data
The datasets supporting the conclusions of this article
are included within the article.
Additional file
Additional file 1: The survey document. (PDF 285 kb)
Abbreviations
95%CI: 95 % confidence interval; BOTA: British Orthopaedic Trainees
Association; Df: degrees of freedom; NDORMS: Nuffield Department of
Orthopaedics, Rheumatology and Musculoskeletal Sciences; OR: odds ratio;
RCT: randomised controlled trial; SPSS: statistical package for the social
sciences; UK: United Kingdom.
Competing interests
This survey was performed in relation to a placebo-controlled surgical trial
on shoulder pain (NCT01623011), in which KW and AJC are involved.
Authors’ contributions
All authors were involved in the study’s concept and design, data analysis,
drafting of the manuscript and the critical revision of the manuscript for
important intellectual content. All authors had full access to all of the data
in the study and can take responsibility for the integrity of the data and the
accuracy of the data analysis. All authors revised and approved the final
version of the article.
Funding
The study was funded by the NIHR Musculoskeletal Biomedical Research
Unit. The funder had no role in the design and conduct of the study;
collection, management, analysis and interpretation of the data; preparation,
review or approval of the manuscript; and decision to submit the manuscript
for publication.
Author details
1Oxford NIHR Musculoskeletal Biomedical Research Unit, Old Road, Oxford
OX3 7LD, UK. 2The Botnar Institute of Musculoskeletal Sciences, Nuffield
Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
(NDORMS), University of Oxford, Old Road, Oxford OX3 7LD, UK.
Received: 15 October 2015 Accepted: 20 April 2016
References
1. Kable AK, Gibberd RW, Spigelman AD. Adverse events in surgical patients in
Australia. Int J Qual Health Care. 2002;14(4):269–76.
2. Zegers M, de Bruijne M, de Keizer B, Merten H, Groenewegen P, van der
Wal G, Wagner C. The incidence, root-causes, and outcomes of adverse
events in surgical units: implication for potential prevention strategies.
Patient Safety Surgery. 2011;5(1):13.
3. McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC,
Nicholl J. No surgical innovation without evaluation: the IDEAL
recommendations. Lancet. 2009;374(9695):1105–12.
4. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of
clinical trials comparing placebo with no treatment. N Engl J Med. 2001;
344(21):1594–602.
5. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo
effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565–90.
6. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious
expectation and unconscious conditioning in analgesic, motor, and
hormonal placebo/nocebo responses. J Neurosci. 2003;23(10):4315–23.
7. Thomas KB. General practice consultations: is there any point in being
positive? BMJ. 1987;294(6581):1200–2.
8. Benedetti F. How the doctor’s words affect the patient’s brain. Eval Health
Prof. 2002;25(4):369–86.
9. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have
enhanced placebo effects? J Clin Epidemiol. 2000;53(8):786–92.
10. Macklin R. The ethical problems with sham surgery in clinical research.
N Engl J Med. 1999;341(13):992–6.
11. Biller-Andorno N. The use of the placebo effect in clinical medicine - ethical
blunder or ethical imperative? Sci Eng Ethics. 2004;10:43–50.
12. Rich B. A placebo for the pain: a medico-legal case analysis. Pain Med. 2003;
4:366–72.
13. Fassler M, Meissner K, Schneider A, Linde K. Frequency and circumstances of
placebo use in clinical practice - a systematic review of empirical studies.
BMC Medicine. 2010;8(1):15.
14. Shapiro A, Struening E. Defensiveness in the definition of placebo. Compr
Psychiatry. 1973;14:107–20.
15. Wartolowska K, Beard DJ, Carr AJ. Attitudes and beliefs about placebo
surgery among orthopedic shoulder surgeons in the United Kingdom.
PLoS ONE. 2014;9(3), e91699.
16. Sherman R, Hickner J. Academic physicians use placebos in clinical practice
and believe in the mind-body connection. J Gen Intern Med. 2008;23:7–10.
17. Nitzan U, Lichtenberg P. Questionnaire survey on use of placebo. BMJ.
2004;329:944–6.
18. Fassler M, Gnadinger M, Rosemann T, Biller-Andorno N. Use of placebo
interventions among Swiss primary care providers. BMC Health Serv Res.
2009;9:144.
19. Gracely RH, Dubner R, Deeter WR, Wolskee PJ. Clinicians’ expectations
influence placebo analgesia. Lancet. 1985;1(8419):43.
20. Wartolowska K, Judge A, Hopewell S, Collins GS, Dean BJF, Rombach I,
Brindley D, Savulescu J, Beard DJ, Carr AJ. Use of placebo controls in the
evaluation of surgery: systematic review. BMJ. 2014;348:g3253.
21. Raz A, Campbell N, Guindi D, Holcroft C, Dery C, Cukier O. Placebos in clinical
practice: comparing attitudes, beliefs, and patterns of use between academic
psychiatrists and nonpsychiatrists. Can J Psychiatry. 2011;56(4):198–208.
22. Hrobjartsson A, Norup M. The use of placebo interventions in medical practice - a
national questionnaire survey of Danish clinicians. Eval Health Prof. 2003;26:153–65.
23. Berger J. Placebo medication use in patient care: a survey of medical
interns. West J Med. 1999;170:93–6.
24. Wright JG, Katz JN, Losina E. Clinical trials in orthopaedics research. Part I.
Cultural and practical barriers to randomized trials in orthopaedics. J Bone
Joint Surg Am. 2011;93(5):e15. doi:10.2106/JBJS.J.00229.
25. Khan Y, Palmer J, Briggs T. ST3 recruitment in trauma and orthopaedics:
what are the characteristics of successful candidates? In: BMJ Careers. 2014.
Baldwin et al. BMC Surgery  (2016) 16:27 Page 8 of 8
